Product Description:

Tazobrixx™ contains Piperacillin and Tazobactam for Injection IP (standard 4.5g ratio). Piperacillin provides a broad range of antibacterial activity, while Tazobactam protects it from destruction by certain bacterial enzymes, making it highly effective against resistant pathogens.

Key Benefits

• Extended-Spectrum Coverage: Highly active against Gram-positive, Gram-negative, and Anaerobic pathogens.
• Beta-Lactamase Protection: The addition of Tazobactam ensures the drug remains effective even against enzyme-producing "superbugs."
• Trusted in ICUs: A first-line choice for treating severe hospital-acquired infections.
• Dual Action: Works by inhibiting bacterial cell wall synthesis while simultaneously neutralizing bacterial defenses.

Indications

• Moderate-to-Severe Nosocomial Pneumonia
• Complicated Intra-abdominal Infections (Peritonitis)
• Complicated Skin and Soft Tissue Infections
• Pelvic Inflammatory Disease (PID)
• Community-Acquired Pneumonia

Dosage & Administration

• Route: For Intravenous (IV) Infusion only
• Form: Lyophilized powder for injection (Reconstitute with compatible diluent)
• Dosage: Typically 4.5g every 6 to 8 hours, or as prescribed by a specialist
• Storage: Store below 25°C, protected from light and moisture
• Warning: Contraindicated in patients with a history of allergic reactions to Penicillins or Cephalosporins.